E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/13/2005 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: Sunshine Heart raises A$3.3 million in stock offering

By Sheri Kasprzak

New York, Dec. 13 - Sunshine Heart Inc. said it has completed a private placement of stock for A$3,295,500.

The company issued 16.9 million Chess Depository Interests at A$0.195 each to institutional and sophisticated investors.

Intersuisse Corporate Pty. Ltd. was the placement agent.

Proceeds will be used to increase the rate of recruitment of patients for a long-term clinical trial.

Based in St. Leonards, New South Wales, Australia, Sunshine Heart is a medical device company focused on products to assist patients with long-term heart failure.

Issuer:Sunshine Heart Inc.
Issue:Chess Depository Interests
Amount:A$3,295,500
CDIs:16.9 million
Price:A$0.195
Warrants:No
Placement agent:Intersuisse Corporate Pty. Ltd.
Settlement date:Dec. 13
Stock price:A$0.20 at close Dec. 13

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.